ArticleJournal of health economics and outcomes research2020

A Systematic Literature Review and Bucher Indirect Comparison: Tildrakizumab versus Guselkumab.

Kristian Garn Du Jardin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.